{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:03:10Z","timestamp":1771567390099,"version":"3.50.1"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Non-erosive reflux disease (NERD), the most frequent phenotype of gastroesophageal reflux disease, presents without visible esophageal mucosal damage but significantly impacts patients' quality of life. Current treatments like proton pump inhibitors show limited efficacy for many NERD patients, necessitating alternative approaches. Jianpi Qinghua (JQ) granules, a traditional Chinese medicine, have shown promise in treating NERD by targeting symptoms of spleen deficiency and damp-heat syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Purpose<\/jats:title><jats:p>This study aims to evaluate the efficacy and safety of JQ granules in treating patients with NERD characterized by spleen deficiency and damp-heat syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study design<\/jats:title><jats:p>A multicenter, randomized, double-blind, placebo-controlled clinical trial was conducted with a total of 78 NERD patients randomly assigned to receive either JQ granules or placebo for 4 weeks, followed by a 4-week follow-up period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Seventy-eight NERD patients with spleen deficiency and damp-heat syndrome were recruited and randomly assigned to receive either JQ granules (<jats:italic>n<\/jats:italic> = 39) or placebo (<jats:italic>n<\/jats:italic> = 39). The trial included a 1-week lead-in, followed by a 4-week double-blind treatment, and a 4-week follow-up. Primary endpoints were the improvement rates of reflux and heartburn symptoms and VAS score changes. Secondary endpoints included atypical symptom scores, total TCM syndrome scores, GERD Health-Related Quality-of-Life (HRQL), and self-rated depression and anxiety scales. Safety assessments involved routine blood, urine, and liver and kidney function tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After 4 weeks, the improvement rate for reflux or heartburn symptoms was 79.49% in the JQ group vs. 58.97% in the placebo group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). VAS scores showed significant reductions in both groups but without notable inter-group differences. Total TCM syndrome scores significantly decreased in both groups, with the JQ group showing greater improvement trends. The JQ group had higher rates of effective TCM syndrome improvement and better GERD-HRQL scores. Both groups saw significant reductions in self-rated depression and anxiety scores, with trends favoring JQ granules. Safety assessments were comparable between groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>JQ granules significantly outperform placebo in treating NERD symptoms and display long-term effectiveness. They effectively address spleen deficiency and damp-heat syndrome, improving patients' social functioning, and have a favorable safety profile.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p><jats:ext-link>https:\/\/clinicaltrials.gov\/study\/NCT04324138?term=NCT04324138&amp;amp;rank=1<\/jats:ext-link>, identifier: NCT04324138.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2024.1509931","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T07:59:48Z","timestamp":1736236788000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of Jianpi Qinghua granules for non-erosive reflux disease with spleen deficiency and damp-heat syndrome: a multicenter, randomized, double-blind, placebo-controlled clinical trial"],"prefix":"10.3389","volume":"11","author":[{"given":"Tai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijie","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/nyas.13845","article-title":"Nonerosive reflux disease: clinical concepts","volume":"1434","author":"Gyawali","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bpg.2014.11.002","article-title":"Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects","volume":"29","author":"Roman","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"Clinical guideline for the diagnosis and management of gastroesophageal reflux disease","volume":"117","author":"Katz","year":"2022","journal-title":"Am J Gastroenterol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2036.1995.tb00347.x","article-title":"comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre investigational group","volume":"9","author":"Robinson","year":"1995","journal-title":"Aliment Pharmacol Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1572-0241.2001.03600.x","article-title":"Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial","volume":"96","author":"Richter","year":"2001","journal-title":"Am J Gastroenterol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dote.12511","article-title":"The natural history of gastro-esophageal reflux disease: a comprehensive review","volume":"30","author":"Savarino","year":"2017","journal-title":"Dis Esophagus."},{"key":"B8","doi-asserted-by":"publisher","first-page":"8408","DOI":"10.3748\/wjg.v19.i45.8408","article-title":"Proton pump inhibitor for non-erosive reflux disease: a meta-analysis","volume":"19","author":"Zhang","year":"2013","journal-title":"World J Gastroenterol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"9865963","DOI":"10.1155\/2017\/9865963","article-title":"Meta-analysis and systematic review of the efficacy of twice daily PPIs versus once daily for treatment of gastroesophageal reflux disease","volume":"2017","author":"Zhang","year":"2017","journal-title":"Gastroenterol Res Pract."},{"key":"B10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.dld.2012.11.017","article-title":"Predictors of clinical response of acid suppression in Chinese patients with gastroesophageal reflux disease","volume":"45","author":"Wang","year":"2013","journal-title":"Dig Liver Dis."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.012","article-title":"Functional esophageal disorders","author":"Aziz","year":"2016","journal-title":"Gastroenterology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00535-022-01861-z","article-title":"Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021","volume":"57","author":"Iwakiri","year":"2022","journal-title":"J Gastroenterol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1365-2036.2010.04358.x","article-title":"Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease","volume":"32","author":"Boeckxstaens","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/MAJ.0b013e3181ad584a","article-title":"Role of the gastric refluxate in gastroesophageal reflux disease: acid, weak acid and bile","volume":"338","author":"Richter","year":"2009","journal-title":"Am J Med Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"153584","DOI":"10.1016\/j.phymed.2021.153584","article-title":"JianpiQinghua granule reduced PPI dosage in patients with nonerosive reflux disease: A multicenter, randomized, double-blind, double-dummy, noninferiority study","volume":"88","author":"Zhang","year":"2021","journal-title":"Phytomedicine."},{"key":"B16","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1186\/s13063-022-06811-x","article-title":"Traditional Chinese medicine based on Tongjiang methodology combined with proton pump inhibitor (PPI) step-down in treating non-erosive reflux disease: a study protocol for a multicentered, randomized controlled clinical trial","volume":"23","author":"Li","year":"2022","journal-title":"Trials."},{"key":"B17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.psym.2015.10.007","article-title":"GERD: an alternative perspective","volume":"57","author":"Ho","year":"2016","journal-title":"Psychosomatics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1365-2036.2011.04901.x","article-title":"Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care\u2013the ProGERD study","volume":"35","author":"Malfertheiner","year":"2012","journal-title":"Aliment Pharmacol Ther."},{"key":"B19","first-page":"155","article-title":"Expert consensus opinions on gastroesophageal reflux disease in China 2014","volume":"20","author":"Chen","year":"2015","journal-title":"Chin J Gastroenterol."},{"key":"B20","first-page":"170","article-title":"Consensus opinions on gastroesophageal reflux disease in China (2006\u00b710 Sanya)","volume":"46","author":"Lin","year":"2007","journal-title":"Chin J Intern Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s11655-016-2596-9","article-title":"Therapeutic effect of Chang'an i recipe (i) on irritable bowel syndrome with diarrhea: a multicenter randomized double-blind placebo-controlled clinical trial","volume":"24","author":"Tang","year":"2018","journal-title":"Chin J Integr Med."},{"key":"B22","unstructured":"Exploration into the preparation of placebos used in Chinese medicinal clinical trial\n          \n          656\n          8\n          \n            \n              Tang\n              X-D\n            \n            \n              Bian\n              L-Q\n            \n            \n              Gao\n              R\n            \n          \n          Zhongguo Zhong Xi Yi Jie He Za Zhi\n          29\n          2009"},{"key":"B23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1442-2050.2007.00658.x","article-title":"The development of the GERD-HRQL symptom severity instrument","volume":"20","author":"Velanovich","year":"2007","journal-title":"Dis Esophagus."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11655-015-2114-5","article-title":"Randomized double-blind clinical trial of Moluodan () for the treatment of chronic atrophic gastritis with dysplasia","volume":"22","author":"Tang","year":"2016","journal-title":"Chin J Integr Med"},{"key":"B25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/1097-4679(197210)28:4<539::AID-JCLP2270280427>3.0.CO;2-S","article-title":"The depression status inventory: an adjunct to the self-rating depression scale","volume":"28","author":"Zung","year":"1972","journal-title":"J Clin Psychol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1055\/s-2007-1017407","article-title":"Demographic factors influencing psychiatric rating scales (Zung SDS and SAS)","volume":"17","author":"Merz","year":"1984","journal-title":"Pharmacopsychiatry."},{"key":"B27","first-page":"143","volume-title":"Guiding Principle of Clinical Research on New Drugs of Traditional Chinese Medicine","author":"Zheng","year":"2002"},{"key":"B28","first-page":"81","article-title":"Treatment of gastroesophageal reflux disease with enteric-coated esomeprazole tablets: a study of 130 cases","volume":"24","author":"Wang","year":"2015","journal-title":"China Pharmaceuticals."},{"key":"B29","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3969\/j.issn.1671-038X.2017.10.07","article-title":"Clinical Efficacy Study of the Xin-Kai-Ku-Jiang Method in Treating Non-Erosive Gastroesophageal Reflux Disease","volume":"25","author":"Wei","year":"2017","journal-title":"Chin J Integrat Trad Western Med Digest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.gastro.2017.07.045","article-title":"Presentation and epidemiology of gastroesophageal reflux disease","volume":"154","author":"Richter","year":"2018","journal-title":"Gastroenterology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/j.1572-0241.2004.04164.x","article-title":"Gastroesophageal reflux disease: a typical spectrum disease (a new conceptual framework is not needed)","volume":"99","author":"Pace","year":"2004","journal-title":"Am J Gastroenterol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.cgh.2019.07.015","article-title":"Phenotypes of gastroesophageal reflux disease: where Rome, Lyon, and Montreal meet","volume":"18","author":"Katzka","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/00365520510011579","article-title":"High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report","volume":"40","author":"Ronkainen","year":"2005","journal-title":"Scand J Gastroenterol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.dld.2020.10.003","article-title":"Esophageal reflux hypersensitivity: Non-GERD or still GERD?","volume":"52","author":"Savarino","year":"2020","journal-title":"Dig Liver Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.dld.2003.10.012","article-title":"Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)\u2013a reappraisal 10 years on","volume":"36","author":"Pace","year":"2004","journal-title":"Dig Liver Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/jgh.15758","article-title":"Thailand guideline 2020 for medical management of gastroesophageal reflux disease","volume":"37","author":"Maneerattanaporn","year":"2022","journal-title":"J Gastroenterol Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1053\/j.gastro.2017.04.047","article-title":"Complications of proton pump inhibitor therapy","volume":"153","author":"Vaezi","year":"2017","journal-title":"Gastroenterology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"CD011969","DOI":"10.1002\/14651858.CD011969.pub2","article-title":"Deprescribing versus continuation of chronic proton pump inhibitor use in adults","volume":"3","author":"Boghossian","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1505394","DOI":"10.1155\/2018\/1505394","article-title":"Efficacy and safety of traditional Chinese medicine on nonerosive reflux disease: a meta-analysis of randomized controlled trials","volume":"2018","author":"Xiao","year":"2018","journal-title":"Evid Based Complement Alternat Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/01.mcg.0000225631.07039.6d","article-title":"Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics","volume":"41","author":"Fass","year":"2007","journal-title":"J Clin Gastroenterol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/aje\/kwi218","article-title":"Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus","volume":"162","author":"Ford","year":"2005","journal-title":"Am J Epidemiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2011-301389","article-title":"Gender differences in oesophageal mucosal injury in a reflux oesophagitis model of rats","volume":"62","author":"Masaka","year":"2013","journal-title":"Gut."},{"key":"B43","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/00042737-200405000-00010","article-title":"Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study","volume":"16","author":"Rosaida","year":"2004","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e6491","DOI":"10.7717\/peerj.6491","article-title":"A population-based study on prevalence and risk factors of gastroesophageal reflux disease in the Tibet Autonomous Region, China","volume":"7","author":"Zhang","year":"2019","journal-title":"PeerJ."},{"key":"B45","doi-asserted-by":"publisher","first-page":"6410","DOI":"10.3748\/wjg.v28.i45.6410","article-title":"Meta-analysis on the epidemiology of gastroesophageal re?","volume":"28","author":"Lu","year":"2022","journal-title":"World J Gastroenterol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2036.2010.04315.x","article-title":"Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease","volume":"32","author":"Cremonini","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/ajg.2011.146","article-title":"Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease","volume":"106","author":"Kahrilas","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e00101","DOI":"10.14309\/ctg.0000000000000101","article-title":"Efficacy and safety of vonoprazan in patients with nonerosive gastroesophageal reflux disease: a randomized, placebo-controlled, phase 3 study","volume":"10","author":"Kinoshita","year":"2019","journal-title":"Clin Transl Gastroenterol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"6369","DOI":"10.1002\/ptr.7288","article-title":"Myrtle (Myrtus communis L","volume":"35","author":"Paknejad","year":"2021","journal-title":"Phytother Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ctim.2019.06.007","article-title":"Comparison of the efficacy of ranitidine and quince syrup on gastroesophageal reflux disease in children","volume":"45","author":"Naeimi","year":"2019","journal-title":"Complement Ther Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ctcp.2015.09.005","article-title":"Effects of Quince syrup on clinical symptoms of children with symptomatic gastroesophageal reflux disease: a double-blind randomized controlled clinical trial","volume":"21","author":"Zohalinezhad","year":"2015","journal-title":"Complement Ther Clin Pract."},{"key":"B52","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0254-6272(15)30151-5","article-title":"Efficacy and safety of Aloe vera syrup for the treatment of gastroesophageal reflux disease: a pilot randomized positive-controlled trial","volume":"35","author":"Panahi","year":"2015","journal-title":"J Tradit Chin Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1365-2036.2007.03527.x","article-title":"the measurement of non-acid gastro-oesophageal reflux","volume":"26","author":"Smout","year":"2007","journal-title":"Aliment Pharmacol Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cgh.2012.01.022","article-title":"Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease","volume":"10","author":"Kahrilas","year":"2012","journal-title":"Clini Gastroenterol Hepatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"307805","DOI":"10.1155\/2014\/307805","article-title":"The effects of baclofen for the treatment of gastroesophageal reflux disease: a meta-analysis of randomized controlled trials","volume":"2014","author":"Li","year":"2014","journal-title":"Gastroenterol Res Pract."},{"key":"B56","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1136\/gut.52.10.1397","article-title":"Effect of the GABAB agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors","volume":"52","author":"Koek","year":"2003","journal-title":"Gut."},{"key":"B58","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/MOO.0000000000000486","article-title":"Laryngopharyngeal reflux disease: clinical presentation, diagnosis and therapeutic challenges in 2018","volume":"26","author":"Lechien","year":"2018","journal-title":"Curr Opin Otolaryngol Head Neck Surg."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11894-020-00780-4","article-title":"Non-acid reflux: when it matters and approach to management","volume":"22","author":"Zikos","year":"2020","journal-title":"Curr Gastroenterol Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/j.1572-0241.2008.01791.x","article-title":"Characteristics of symptomatic reflux episodes on acid suppressive therapy","volume":"103","author":"Tutuian","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1111\/j.1572-0241.2006.00711.x","article-title":"Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy","volume":"101","author":"Zerbib","year":"2006","journal-title":"Am J Gastroenterol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.15403\/jgld-4196","article-title":"Romanian guidelines for the diagnosis and treatment of gerd-induced respiratory manifestations","volume":"31","author":"Drug","year":"2022","journal-title":"J Gastroenterol Liver Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1111\/j.1572-0241.2005.50209.x","article-title":"Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group","volume":"100","author":"Zentilin","year":"2005","journal-title":"Am J Gastroenterol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"G323","DOI":"10.1152\/ajpgi.00345.2013","article-title":"Hypersensitivity to acid is associated with impaired esophageal mucosal integrity in patients with gastroesophageal reflux disease with and without esophagitis","volume":"307","author":"Weijenborg","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1136\/gutjnl-2012-302645","article-title":"In vivo evaluation of acid-induced changes in oesophageal mucosa integrity and sensitivity in non-erosive reflux disease","volume":"62","author":"Woodland","year":"2013","journal-title":"Gut."},{"key":"B66","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/gut.2009.194191","article-title":"Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus","volume":"59","author":"Farr\u00e9","year":"2010","journal-title":"Gut."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/j.1572-0241.2007.01688.x","article-title":"Esophageal dilated intercellular spaces (DIS) and nonerosive reflux disease","volume":"103","author":"Van Malenstein","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1136\/gut.2006.115881","article-title":"Intraluminal acid induces oesophageal shortening via capsaicin-sensitive neurokinin neurons","volume":"56","author":"Paterson","year":"2007","journal-title":"Gut."},{"key":"B69","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/labinvest.2011.139","article-title":"Acid modulates the squamous epithelial barrier function by modulating the localization of claudins in the superficial layers","volume":"92","author":"Oshima","year":"2012","journal-title":"Laborat investigat."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1136\/gut.2007.141804","article-title":"Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces","volume":"57","author":"Farre","year":"2008","journal-title":"Gut."},{"key":"B71","doi-asserted-by":"publisher","first-page":"G487","DOI":"10.1152\/ajpgi.00370.2015","article-title":"A weakly acidic solution containing deoxycholic acid induces esophageal epithelial apoptosis and impairs integrity in an in vivo perfusion rabbit model","volume":"310","author":"Pardon","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1053\/j.gastro.2004.08.014","article-title":"The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis","volume":"128","author":"Barlow","year":"2005","journal-title":"Gastroenterology."},{"key":"B73","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1440-1746.2012.07266.x","article-title":"Histology of symptomatic gastroesophageal reflux disease: is it predictive of response to proton pump inhibitors?","volume":"28","author":"Miwa","year":"2013","journal-title":"J Gastroenterol Hepatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"987","DOI":"10.13288\/j.11-2166\/r.2017.11.022","article-title":"Expert consensus on traditional chinese medicine diagnosis and treatment of spleen and stomach damp-heat syndrome 2017","volume":"11","author":"Zhang","year":"2017","journal-title":"J Tradit Chin Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.3760\/cma.j.issn.1007-1245.2013.19.005","article-title":"Epidemiological Survey on Traditional Chinese Medicine Syndrome classification in non-erosive gastroesophageal reflux disease","volume":"19","author":"Fu","year":"2013","journal-title":"Int Med Health Guidance News"},{"key":"B76","first-page":"3181","article-title":"The effects of JianpiQinghua granules on activation of esophageal mucosal mast cells in rats with spleen deficiency dampness-heat syndrome of gastroesophageal reflux disease","volume":"24","author":"Che","year":"2022","journal-title":"World Sci Technol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"608","DOI":"10.12114\/j.issn.1007-9572.2021.00.080","article-title":"Anxiety and depression prevalence in chinese patients with gastroesophageal reflux disease: a meta-analysis","volume":"24","author":"Zhou","year":"2021","journal-title":"Chin General Pract."},{"key":"B78","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41395-018-0287-1","article-title":"Revisiting montreal: new insights into symptoms and their causes, and implications for the future of GERD","volume":"114","author":"Hungin","year":"2019","journal-title":"Am J Gastroenterol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.3748\/wjg.v21.i14.4302","article-title":"Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life","volume":"21","author":"Yang","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"593","DOI":"10.5056\/jnm18069","article-title":"Association between anxiety and depression and gastroesophageal reflux disease: results from a large cross-sectional study","volume":"24","author":"Choi","year":"2018","journal-title":"J Neurogastroenterol Motil."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e14177","DOI":"10.1111\/nmo.14177","article-title":"Increased visceral sensitivity, elevated anxiety, and depression levels in patients with functional esophageal disorders and non-erosive reflux disease","volume":"33","author":"Losa","year":"2021","journal-title":"Neurogastroenterol Motility."},{"key":"B82","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/1751-2980.12799","article-title":"Natural history of gastroesophageal reflux: A prospective cohort study in a stratified, randomized population in Beijing","volume":"20","author":"Fang","year":"2019","journal-title":"J Dig Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"741049","DOI":"10.3389\/fpsyt.2021.741049","article-title":"Analysis of psychological and gut microbiome characteristics in patients with non-erosive reflux disease","volume":"12","author":"Yang","year":"2022","journal-title":"Front Psychiat."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2024.1509931\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T07:59:58Z","timestamp":1736236798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2024.1509931\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":83,"alternative-id":["10.3389\/fnut.2024.1509931"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2024.1509931","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"article-number":"1509931"}}